Nonalcoholic Fatty Liver Disease -- New Insight Into a Major Cause of (Hep C Treatment)

Nonalcoholic Fatty Liver Disease -- New Insight Into a Major Cause of
Medscape News - Research presented during this year's meeting of the American Association for the Study of Liver Diseases (AASLD) addressed important advances in our understanding of the hepatic consequences of obesity -- nonalcoholic fatty liver disease (NAFLD), a

Need for treatment modification in older hepatitis C patients
RxPG - "The present data demonstrated the importance of considering patient age when treating hepatitis C via combination therapy, especially for patients more than 60 years old," the authors state. "The treatment schedule should be modified, or other

Car sales dipped to 6.9% in 2005
Daily Pioneer - year gone by has witnessed drastic fall in cars sales. The speed of four-wheeler was dampned by natural disaster afflicting various parts of the country during the year resulting in dip in demand. As per the year-end figures released by Society of

Medivir: Candidate Drug Designated within the Tibotec Collaboration
Genetic Engineering News - The Hepatitis C Virus (HCV) collaboration with Tibotec Pharmaceuticals Ltd has recently designated a Candidate Drug (CD). The aim of the research collaboration is to identify and develop orally active inhibitors of the HCV protease NS3/4A. The